Immunotherapy extends survival in mouse model of hard-to-treat breast cancer

Immunotherapies for cancer -- treatments that prime the immune system to attack tumors -- are valuable weapons in the anti-cancer arsenal. But some cancers are more difficult to target with this strategy than others. Today, scientists report a new immunotherapy that dramatically extends the survival of mice that have triple negative breast tumors, a difficult-to-treat form of cancer.

from Women's Health News -- ScienceDaily https://ift.tt/3kQzBTX